News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
RiverVest Venture Fund IV, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/01/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/05/2021 |
SC 13D
| RiverVest Venture Fund IV, L.P. reports a 5.4% stake in XILIO THERAPEUTICS, INC. |
| 10/26/2021 |
4
| RiverVest Venture Fund IV, L.P. (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 832,120 shares
@ $0
Converted 359,324 shares
@ $0
Bought 250,000 shares
@ $16, valued at
$4M
Converted 832,120 preferred shares
@ $0
Converted 359,324 preferred shares
@ $0 |
|
| 10/21/2021 |
3
| RiverVest Venture Fund IV, L.P. (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 04/13/2021 |
4
| RiverVest Venture Fund III, L.P. (10% Owner) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Converted 1,100,765 shares
@ $0
Converted 829,113 shares
@ $0
Bought 200,000 shares
@ $15, valued at
$3M
Converted 4,925,711 preferred shares
@ $0
Converted 3,710,116 preferred shares
@ $0 |
|
| 04/08/2021 |
3
| RiverVest Venture Fund III, L.P. (10% Owner) has filed a Form 3 on Reneo Pharmaceuticals, Inc. |
| 12/22/2020 |
SC 13D/A
| RiverVest Venture Fund IV, L.P. reports a 6.6% stake in MIRUM PHARMACEUTICALS, INC. |
| 10/16/2020 |
4
| RiverVest Venture Fund III, L.P. (10% Owner) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.|
Txns:
| Converted 1,070,172 shares
@ $0
Converted 828,109 shares
@ $0
Bought 250,000 shares
@ $15, valued at
$3.8M
Converted 7,000,000 preferred shares
@ $0
Converted 5,416,666 preferred shares
@ $0 |
|
| 10/08/2020 |
3
| RiverVest Venture Fund III, L.P. (10% Owner) has filed a Form 3 on SPRUCE BIOSCIENCES, INC. |
| 08/01/2019 |
SC 13D
| RiverVest Venture Fund IV, L.P. reports a 8.4% stake in MIRUM PHARMACEUTICALS, INC. |
| 10/09/2018 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 12/14/2017 |
D
| Form D - Notice of Exempt Offering of Securities: |
|
|